Iodinated Choline Transport-Targeted Tracers
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60461373%3A22330%2F20%3A43923099" target="_blank" >RIV/60461373:22330/20:43923099 - isvavai.cz</a>
Alternative codes found
RIV/61389013:_____/20:00536679 RIV/00216208:11310/20:10422520 RIV/61989592:15110/20:73602636
Result on the web
<a href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01710" target="_blank" >https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01710</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1021/acs.jmedchem.0c01710" target="_blank" >10.1021/acs.jmedchem.0c01710</a>
Alternative languages
Result language
angličtina
Original language name
Iodinated Choline Transport-Targeted Tracers
Original language description
We present a novel series of radioiodinated tracers and potential theranostics for diseases accompanied by pathological function of proteins involved in choline transport. Unlike choline analogues labeled with 11C or 18F that are currently used in the clinic, the iodinated compounds described herein are applicable in positron emission tomography, single-photon emission computed tomography, and potentially in therapy, depending on the iodine isotope selection. Moreover, favorable half-lives of iodine isotopes result in much less challenging synthesis by isotope exchange reaction. Six of the described compounds were nanomolar ligands, and the best compound possessed an affinity 100-fold greater than that of choline. Biodistribution data of 125I-labeled ligands in human prostate carcinoma bearing (PC-3) mice revealed two compounds with a biodistribution profile superior to that of [18F]fluorocholine. © 2020 American Chemical Society. All rights reserved.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10404 - Polymer science
Result continuities
Project
<a href="/en/project/TE01020028" target="_blank" >TE01020028: Center for Development of Original Drugs</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of Medicinal Chemistry
ISSN
0022-2623
e-ISSN
—
Volume of the periodical
63
Issue of the periodical within the volume
24
Country of publishing house
US - UNITED STATES
Number of pages
19
Pages from-to
15960-15978
UT code for WoS article
000603401900045
EID of the result in the Scopus database
2-s2.0-85097899954